M
NR 667 CEA FNP FINAL EXAM 2025 QUE
g g g g g g g
STIONS AND CORRECT ANSWERS GRA
g g g g
DED A+ g
Agpatientgcurrentlygundergoinggconcurrentgchemotherapy/radiationgtreatmentgforgglotticgsquamousgcel
lgcarcinomagisgadmittedgtogthegrehabgunitgyougoverseegforgmanagementgofgintractablegnausea,gvomitin
g,gandgdehydration.gAdmissiongCBCgshowedgWBCg1.3,gHgbg7.5,gPLTg45,gANCg0.8.gWhichgofgthegfollowin
ggconditionsgisgthisgpatientgatgriskgfor?
A. MacrocyticganemiagduegtogB12gdeficiency
B. Irongdeficiencyganemiagduegtogchronicgbloodgloss
C. Microcyticganemiagduegtogchronicgkidneygdisease
D. Aplasticganemiagduegtogbonegmarrowgsuppression
D
Yourgpatientgpresentsgtogthegurgentgcaregclinicgwithgagswollengexudativegpharynx,gprofoundgfatigue,gan
dgagverygtendergleftguppergquadrantgabdomen.gWhatgisgthegmostglikelygdiagnosis?
A. Strepgpharyngitis
B. Tonsillitis
C. EpsteingBarrgvirusg(EBV)
,NRg667gCEAgFNPgEXA
M
D. Pancreatitis
gC
Whichgofgthegfollowinggbestgcharacterizesgpresbycusisgingthegoldergadult?
A. Bilateralglow-frequencygsensorineuralghearinggloss
B. Bilateralghigh-frequencygsensorineuralghearinggloss
C. Unilateralghigh-frequencygsensorineuralghearinggloss
D. Unilateralglow-
frequencygsensorineuralghearingglossgB
Ag35-year-
oldgwomangpresentsgwithgallergicgrhinitis,gexperiencinggsignificantgnasalgcongestion,gsneezing,gandgitchy
geyes.gSheghasgtriedgover-the-
countergantihistaminesgwithglimitedgrelief.gWhatgisgthegmostgappropriategnextgstepgingmanagement?
A. Oralgdecongestants
B. Nasalgsalinegirrigation
C. Intranasalgcorticosteroids
D. Referralgtogangallergistgforgimmunotherapy
C
,NRg667gCEAgFNPgEXA
M
Agpatientgcurrentlygundergoinggconcurrentgchemotherapy/radiationgtreatmentgforgglotticgsquamousgcel
lgcarcinomagisgadmittedgtogthegrehabgunitgyougoverseegforgmanagementgofgintractablegnausea,gvomitin
g,gandgdehydration.gAdmissiongCBCgshowedgWBCg1.3,gHgbg7.5,gPLTg45,gANCg0.8.gWhichgofgthegfollowin
ggconditionsgisgthisgpatientgatgriskgfor?
A. Irongdeficiencyganemiagduegtogchronicgbloodgloss
B. Microcyticganemiagduegtogchronicgkidneygdisease
C. MacrocyticganemiagduegtogB12gdeficiency
D. Aplasticganemiagduegtogbonegmarrowgsuppressio
ngD
Ag78gy.o.gMgpatientgreportsgchronicginfections,gbruising,gfatigue,gSOB,gandgfevers.gHeghasgaghistorygofgr
ectalgadenocarcinomagandgcompletedgconcurrentgchemotherapy/radiationgearliergthisgyear.gHisgCBCgsh
owsgHgbg7.5,gPLTg88,gWBCg1.2,gANCg0.8,gandgperipheralgsmeargshowsgdysplasia.gWhatgadditionalgwork-
gupgwouldgyouganticipategforgthisgpatient?
A. Colonoscopygandgfecalgoccultgbloodgtest
B. Bonegmarrowgbiopsygandgflowgcytometry
C. Nogadditionalgwork-upgisgrequired,gthesegaregexpectedgsequelagofghisgoncologicgtreatment
D. RepeatgCBC/CMP/peripheralgsmeargingeightgweek
sgB
ProgressiongtogAcutegMyelogenousgLeukemiag(AML)gisgagriskgforguntreatedgorgpoorlygresponsive:
, NRg667gCEAgFNPgEXA
M
A. Pancytopenia
B. Aplasticganemia
C. Macrocyticganemia
D. Myelodysplasticgsyndrome
D
Treatmentgforgsymptomaticgaplasticganemiagincludesgallgthegfollowinggexcept:
A. Bonegmarrowgtransplant
B. PRBC/Platelet/WBCg transfusions
C. Prophylacticgantibiotics
D. Removalgofgbonegmarrowgstimulants
D
Agpatientgdiagnosedgwithgirongdeficiencyganemiagrequiresgirongsupplementation.gWhichgofgthegfollowin
ggtreatmentsgwouldglikelygbegineffective?